Udenafil Market

Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.
Udenafil Market contains market size and forecasts of Udenafil in global, including the following market information:
Global Udenafil Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Udenafil Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Udenafil companies in 2021 (%)
The global Udenafil market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Udenafil include Dong-A Pharmaceutical and Zydus Life etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Udenafil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Udenafil Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Udenafil Market Segment Percentages, by Type, 2021 (%)
100mg
200mg
Global Udenafil Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Udenafil Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Retail Pharmacies
Others
Global Udenafil Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Udenafil Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Udenafil revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Udenafil revenues share in global market, 2021 (%)
Key companies Udenafil sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Udenafil sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dong-A Pharmaceutical
Zydus Life